在真实疫情下919株牛流行热病毒疫苗的效果:以色列奶牛群的现场研究
在以色列2021年牛流行热疫情中开展随机对照现场疫苗效果研究,纳入11个奶牛群中4个自然感染群的120头接种与311头未接种牛。混合效应Cox回归显示疫苗预防临床疾病的平均效果为60%(95%CI=38%-77%),死亡保护趋势未达统计学显著(p=0.1)。
要点
- 疫苗预防临床疾病的平均效果为60%(95%CI=38%-77%)。
- 未接种组死亡率为2.61%(7/311),接种组未见死亡,保护趋势p=0.1未达统计学显著。
- 接种且临床发病者中和抗体滴度最高,提示接种后存在加强效应。
核心结论
- 研究结果为ULTRAVAC BEF VACCINE™预防牛流行热提供中等效果的证据。
研究设计与样本
- 在以色列2021年牛流行热疫情期间开展随机对照现场疫苗效果研究,纳入11个奶牛群,用电子监测标签监测牛流行热相关发病与反刍改变模式。
主要发现
- 4个奶牛群在疫情期间自然感染牛流行热病毒,共120头接种牛和311头未接种牛纳入效果研究。
- 混合效应Cox比例风险回归模型计算接种与未接种牛的总风险比,显示预防临床疾病的平均疫苗效果为60%(95%CI=38%-77%)。
- 观察到针对死亡的保护呈非统计学显著趋势(p=0.1),接种组未见死亡,未接种组死亡率为2.61%(7/311)。
- 对来自感染群和非感染群、不同发病状态的130头接种与未接种犊牛进行血清中和试验,接种且临床发病者牛流行热病毒中和抗体滴度最高,提示接种后存在加强效应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bovine ephemeral fever virus (BEFV) is a globally spread arthropod-borne RNA virus that has significant economic impacts on the cattle industry. A live attenuated commercial BEF vaccine, based on the Australian BEFV strain 919, is widely used in Israel and other countries. A previous study has suggested the high effectiveness of this vaccine (ULTRAVAC BEF VACCINE™ from Zoetis®), but anecdotal reports of high BEF morbidity among vaccinated dairy herds in Israel casted doubt on these findings. To resolve this uncertainty, a randomized controlled field vaccine effectiveness study was conducted in Israel during a BEF outbreak which occurred in 2021. Eleven dairy herds were enrolled and monitored for BEF-associated morbidity and rumination alteration patterns using electronic monitoring tags (HR Tags, SCR® Dairy, Netanya, Israel). Four of the herds were naturally infected with BEFV during the outbreak, resulting in a total of 120 vaccinated and 311 unvaccinated subjects that were included in the effectiveness study. A mixed-effect Cox proportional hazard regression model was used to calculate the overall hazard ratio between vaccinated and unvaccinated cattle. This analysis demonstrated an average vaccine effectiveness of 60 % (95 % CI = 38 %-77 %) for preventing clinical disease. In addition, a non-statistically significant trend (p = 0.1) towards protection from mortality was observed, with no observation of mortality among the vaccinated groups compared to 2.61 % mortality (7/311) among the unvaccinated subjects. One hundred and thirty vaccinated and unvaccinated calves from affected and non-affected herds and with different status of morbidity were sampled and analysed by serum-neutralization test. The highest titers of BEFV-neutralizing antibodies were found in subjects that were both vaccinated and clinically affected, indicating a booster effect after vaccination. The results of the study provide evidence for the moderate effectiveness of the ULTRAVAC BEF VACCINE™ for the prevention of BEF.
引用
- Gleser D, Spinner K, Klement E, et al. Effectiveness of the strain 919 bovine ephemeral fever virus vaccine in the face of a real-world outbreak: A field study in Israeli dairy herds. Vaccine. 2023. PMID: 37451879. doi:10.1016/j.vaccine.2023.06.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。